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Abstract 
Background: Temperature modulating devices (TMD) currently utilize core temperature measurements during 
targeted temperature management (TTM) that are currently limited to esophageal (Et), bladder (Bt), or rectal (Rt) 
temperatures. We assessed the ability of a continuous noninvasive temperature monitor to accurately approximate 
core temperature during TTM.
Methods: All patients undergoing TTM using a gel pad surface TMD and an existing core temperature monitoring 
device were eligible for this study. Core and continuous noninvasive temperature monitoring values were simultane‑
ously recorded for up to 72 h of TTM. The two sets of temperature data were downloaded from a clinical data acquisi‑
tion storage system at 1‑min intervals. The Bland–Altman method assessed agreement between the core and con‑
tinuous noninvasive temperature monitor values, by measuring the mean difference (± 2 SD) between these values.
Results: There were 20 subjects that underwent study between January 2018 and March 2018 (55% women, age: 
57 ± 14 years old, BMI: 28.9 + 9.8 kg/m2, 100% mechanically ventilated). The comparison patient temperature source 
was predominantly esophageal (n = 10) followed by bladder (n = 5) or rectal (n = 5). There were a total of 999 h of 
paired patient temperature data from esophageal (50%), bladder (25%), and rectal (25%) temperatures. Bland–Altman 
analysis demonstrated good agreement with the superficial temperature monitor and core temperature measures 
in all patients overall, with a difference mean of 0.06 ± 0.39 C (P = 0.99) and no proportional bias noted (β =0.002, 
P = 0.917).
Conclusions: Continuous noninvasive temperature monitoring is a suitable alternative method for assessing core 
temperature during TTM. Future studies should focus on developing connectivity with a continuous noninvasive 
temperature monitor to approximate core temperature during TTM.
Keywords: Normothermia, Hypothermia, Targeted temperature management, Core temperature, Continuous 
noninvasive temperature monitoring
Introduction
The detrimental effects of hyperthermia in the neuro-
logically injured patient, along with the beneficial effects 
of normothermia, have been widely studied in the criti-
cally ill neurological population [1–3]. For these reasons, 
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targeted temperature management (TTM) has become a 
mainstay therapy in this population.
During TTM, multiple sites are utilized for continu-
ous core temperature monitoring, including bladder, 
esophageal, and rectal probes. The Neurocritical Care 
Society (NCS) TTM guideline suggests that esophageal 
and bladder probes most accurately reflect temperatures 
of pulmonary artery catheters and recommend using 
esophageal temperature probes during TTM [1]. Esopha-
geal probe use is limited to intubated patients, and there 
are increased demands to move away from bladder tem-
perature monitoring in order to prevent catheter-associ-
ated urinary tract infections. Rectal probes are the least 
accurate, and temporal artery probes were not recom-
mended for TTM because they were not accurate and did 
not have continuous monitoring capabilities [1].
The purpose of this study was to determine whether a 
continuous noninvasive temperature monitoring system 
using a continuous temporal artery probe is as accurate 
as the current invasive measures during TTM.
Methods
Patient Selection
This study was a prospective observational study of a 
continuous temperature monitor during TTM. Data col-
lection for this study was approved under an existing IRB 
registry for all patients admitted to our neurocritical care 
unit (NCCU). All adult patients undergoing TTM via a 
gel pad surface temperature modulating device (TMD; 
Arctic-Sun 5000 Temperature Management System, C.R. 
Bard Inc., Louisville, CO) and an existing core tempera-
ture monitoring device (bladder, rectal, or esophageal) 
were eligible for the study.
Target Temperature Management and Temperature 
Monitoring
The noninvasive temperature monitoring system (3M™ 
Bair Hugger™ Temperature Monitoring System, St Paul, 
MN) allows continuous monitoring through a sensor 
placed on the forehead. The prototype device was initially 
studied in a non-emergent cardiac surgery population 
where it demonstrated agreement with the golden stand-
ard Pulmonary Artery (PA) catheter core temperature 
readings [4].
The nursing staff and advanced practice providers were 
in-serviced on use of the continuous noninvasive temper-
ature monitoring system (3M™ Bair Hugger™ Tempera-
ture Monitoring System, St Paul, MN) prior to initiation 
of use in the NCCU. Education included, but was not 
limited to application/removal of sensor, operation/trou-
ble shooting of the control unit, safety monitoring (e.g., 
skin break down under sensor), and contraindications of 
use (e.g., existing skin breakdown). The sensor was placed 
on the lateral forehead and replaced on the contralateral 
side every 24 h per manufacturer recommendations and/
or when the sensor was removed for imaging or the sen-
sor became dislodged such as with profuse diaphoresis 
[5].
Our institution TTM protocol encompasses the use of 
TMDs for controlled normothermia and induced hypo-
thermia. Patients undergoing normothermia (goal 37 °C) 
or hypothermia post-cardiac arrest (goal 32–34 °C prior 
to rewarming) were included in the study. Choice of 
TMD and location of temperature monitoring was left 
to the discretion of the clinical team, with the follow-
ing notable exceptions. Esophageal temperature probes 
(Smiths Medical, Minneapolis, MN) were utilized in 
orally intubated patients who were not utilizing esopha-
geal cooling devices (ECDs-Attune Medical, Chicago, 
IL). Bladder temperature probes (Bard, Covington, GA) 
were utilized in patients when medically indicated (e.g., 
retention, decubitus ulcer). Rectal temperature probes 
(Stryker Medical, Portage, MI) were utilized in non-
intubated patients or patients where foley catheter was 
not indicated or could not be replaced with temperature 
sensing foley catheter for medical reasons (e.g., Benign 
prostatic hyperplasia, prior traumatic insertion, coude 
foley catheter). Nursing assessment and documentation 
included hourly neurological exams, vital signs, Intrac-
ranial Pressure, core temperature, temporal tempera-
ture, and machine water temperature. Skin integrity was 
assessed every 4  h for rash or evidence of breakdown 
from gel pads. Shivering was assessed and treated every 
hour using the bedside shivering assessment scale (BSAS) 
as previously described [6, 7].
Once a patient was determined eligible for the study, a 
disposable skin temperature probe (3M™ Bair Hugger™ 
Temperature Monitoring System, St Paul MN, Sensor 
model 360) was placed on the lateral forehead above the 
eyebrow. The probe was then connected to the monitor-
ing device (3M™ Bair Hugger™ Temperature Monitoring 
System Control Unit, 120 V), which was interfaced with 
the bedside monitor. The core temperature monitoring 
device was connected to the TMD and also interfaced 
with the bedside monitor.
Data Collection
Baseline characteristics collected on patients undergo-
ing TTM included height, weight, BMI, age, gender, 
diagnosis, temperature source, and target temperature. 
Standard anti-shivering interventions were utilized 
during TTM therapy [8]. Due to concerns that shiver-
ing may affect the efficacy of the continuous noninva-
sive temperature monitoring system, we collected data 
on shivering interventions including bedside shivering 
assessment score (BSAS), and any anti-shivering medi-
cations the patients received during TTM.
Core and noninvasive surface temperatures were 
simultaneously recorded for up to 72  h of TTM. 
Continuous temperature data were collected via 
 BedMaster®  (Excel Medical Electronics Inc., Jupiter, 
FL) vital signs collection system beginning at the time 
of TTM initiation. The two sets of temperature data 
were downloaded from the clinical data acquisition 
storage system.
Statistical Analysis
Our primary outcome was agreement between the 
esophageal, bladder, or rectal temperatures and the 
continuous noninvasive temperature monitor temper-
atures with a difference of ≤ 0.5  °C. As in other stud-
ies, we defined 0.5 C a priori as an acceptable limit of 
agreement [9–11]. These limits reflect the normal mag-
nitude of human circadian temperature variation [12, 
13]. We performed a Bland–Altman analysis to evaluate 
agreement between the noninvasive device and each of 
the invasive temperature monitoring devices individu-
ally (rectal, bladder, and esophageal), assuming that the 
true value changes from measurement to measurement 
[14]. In a Bland–Altman analysis, the bias and 95% lim-
its of agreement are determined. The bias, which is esti-
mated by the average difference, summarizes the lack of 
agreement between the two methods, whereas the 95% 
limits of agreement represent where 95% of future dif-
ferences between the two methods would be expected. 
We calculated bias (esophageal temperature minus 
double-sensor temperature or bladder temperature 
minus double-sensor temperature or rectal tempera-
ture minus continuous noninvasive temperature) for 
each outcome and for each time point, and we also cal-
culated the mean bias across all pairs of measurements. 
We created a Bland–Altman plot of bias versus the 
average of each pair of measurements for visual repre-
sentation of the agreement with the standard or refer-
ence core temperature measurements over the range 
of temperatures. For the entire cohort and additionally 
for each site of temperature assessment, proportional 
bias was assessed. This was done by performing a lin-
ear regression whereby the dependent variable was the 
difference between two measures and the independent 
variable was mean temperature for each paired meas-
urement. Regressions with a statistically significant 
result (P < 0.05) were considered to demonstrate pro-
portional bias. All analyses were performed with SPSS 
statistical software (IBM Corp. Released 2019. IBM 




There were 999 h of paired temperature recordings done 
on twenty subjects between January 2018 and May 2018. 
Only one subject was targeted to hypothermia (33  C), 
with the rest (n = 19, 95%) targeted to normothermic 
temperature goals (36–37 C). Esophageal temperature 
was the most common source (n = 10, 50%) with an aver-
age duration of 55.7 ± 17.9 h, followed by rectal tempera-
ture (n = 5, 25%) with an average duration of 51.4 ± 17.2 h 
and bladder temperature (n = 5, 25%) with an average 
duration of 37 ± 21.9 h.
All subjects were endotracheally intubated during the 
study period. No reports of skin irritation or breakdown 
were reported at the skin temperature measurement 
sites.
Shivering was well controlled (BSAS ≤ 1) in 70% of the 
subjects throughout the duration of cooling with moder-
ate use of analgosedation. Paralytics were utilized in two 
patients: one patient as part of rapid sequence intuba-
tion and for ventilator synchrony in another patient with 
acute lung injury (Table 2).
Bland–Altman Analysis of Temperature Measurements 
(Table 3, Fig. 1)
The majority of the paired measurements were done 
in the range of 36.0–38.2  °C (n = 759  h, 76%), with a 
minority done below 36.0  °C (n = 230, 23%) and very 
few ≥ 38.3  °C (n = 10, 1%). No difference in agreement 
was noted with moderate or severe shivering, though 
Table 1 Baseline characteristics
Continuous data shown as mean (SD), categorical data as n (%)
Characteristics N = 20




 Subarachnoid hemorrhage 6(30)
 Intracerebral hemorrhage 7(35)
 Seizure 2(10)
 Cardiac arrest 3(15)
 Ischemic stroke 2(10)
Target temperature (°C)
 33 °C 1(5)
 36 °C 1(5)





there was very little moderate or severe shivering 
(BSAS > 1) noted during the study period. 
There was good agreement with the esophageal core 
temperature with no proportional bias (P = 0.507), 
though as apparent in Fig.  1a, there were some meas-
urements in the range of 36.0–38.0 that were outside 
the 95% boundaries. There was overall greater agree-
ment in the hypothermic range (< 36.0 C). Bladder tem-
perature comparisons showed good agreement with no 
proportional bias (P = 0.342) across the range of temper-
atures (Table 3, Fig. 1b). The paired measurements with 
rectal temperature demonstrated a proportional bias 
(P < 0.001), despite a small difference between measures 
(Table 3, Fig. 1c).
Discussion
In this study of patients undergoing TTM, we evaluated 
a continuous noninvasive temperature monitor against 
currently utilized invasive core temperature monitor-
ing devices including bladder temperature probes, rectal 
temperature probes, and esophageal temperature probes. 
To our knowledge, this is the first comparative analysis of 
a continuous noninvasive temperature monitor to inva-
sive core temperature measures in a population under-
going prolonged TTM. The results demonstrate that the 
continuous noninvasive temperature monitor correlates 
with bladder and esophageal temperature measurements. 
Proportional correlation was identified between the con-
tinuous noninvasive temperature monitor sensor and the 
rectal temperature. This may be due to the known lag 
time between rectal temperature and core temperature 
and the effects of feces and inflammation on temperature 
recordings [15–20].
TTM improves outcomes by reducing effects of the 
primary insult and minimizing the secondary neuro-
logical insult often associated with hypoxic/ischemic 
encephalopathy (HIE) and intracranial hypertension 
[1–3, 21]. Ideally, all patients undergoing TTM should 
have continuous core temperature measurements. The 
surface overlying the temporal artery is an ideal location 
for noninvasive continuous core temperature monitor-
ing because the internal carotid artery supplies it and it 
is a short distance from the aorta [20, 22]. The tempo-
ral artery is void of mucous membranes and has little to 
no arteriovenous anastomoses, providing a continuous 
blood flow free of vasomotor control that could poten-
tially alter the surface temperature [i.e., vasoconstriction] 
[20]. In order for the temporal surface temperature to 
Table 2 Shivering characteristics during TTM
BSAS bedside shivering assessment scale
a Neuromuscular blockade agents used for endotracheal intubation (n = 1) and for management of ARDS (n = 1)
b Cisatracurium used for management of ARDS
Characteristic N = 20 Percent
Shivering (h)
 BSAS = 0 8 40
 BSAS = 0–1 6 30
 BSAS = 0–2 5 25
 BSAS = 0–3 1 5
Medications N = 20 Mean (range)/24 h
Propofol (mcg/kg/min) 7(35) 27 (0–50)
Dexmedetomidine (mcg/kg/h) 7(35) 0.6 (0–1.5)
Fentanyl (mcg/h) 3(15) 94 (0–200)
Morphine (mg/h) 2(10) 4.5 (0–8)
Meperidine (mg) 10(50) 39 (13–100)
Rocuronium (mg)a 2(10) 60 (50–70)
Cisatracurium (mcg/kg/min)b 1(5) 0.4 (0–1.25)
Dantrolene (mg) 1(5) 80 (0–80)
Table 3 Temperature measurements
Measurements Esophageal Core temperature 
measurement sites
Bladder Rectal
Temperature range (°C) 31.5–38.6 34.8–37.8 35.2–37.8
Difference mean ± SD 0.31 ± 0.54 0.2 ± 0.4 0.16 ± 0.38
Significance P = 1.00 P = 1.00 P = 1.00
Linear regression β − 0.01 0.068 0.782
Significance P = 0.507 P = 0.342 P < 0.001
reflect the temporal artery temperature, thermal heat loss 
must be eliminated [20, 23]. The device used in this study 
(3M™ Bair Hugger™ Temperature Monitoring System, 
St Paul MN, Sensor model 360) provides an isothermal 
pathway via a single use sensor placed on the forehead. 
This isothermal pathway is created as the sensor devel-
ops a zone of insulation that eliminates heat loss, thereby 
bringing the core temperature to the skin surface where it 
is continuously recorded and displayed [5, 24].
There has been extensive research comparing multiple 
methods of core temperature monitoring. Heat is bal-
anced between the peripheral and core compartments 
of the body. The core compartment comprises approxi-
mately 50% of the body mass and consists of the well-
perfused deep tissues and organs of the trunk and head 
[25]. The temperature of the core compartment remains 
consistent making it the ideal source for continuous tem-
perature monitoring. The pulmonary artery catheter has 
long been recognized as the gold standard core tempera-
ture monitoring site; however, it is highly invasive, and 
placement/maintenance is not without significant cardiac 
risks [1, 16, 19, 22, 23, 26]. Our study demonstrated accu-
racy between the continuous noninvasive temperature 
monitor and commonly used surrogates for PA cath-
eter—bladder and esophageal probes. Bladder tempera-
tures have been found to be reliable when compared to 
PA catheters [1, 16, 27], but require placement of a foley 
catheter, placing patients at risk for catheter-associated 
urinary tract infections (CAUTI). Temperatures obtained 
from bladder monitoring can be erroneous in patients 
with anuria/oliguria and can lag behind core tempera-
tures during rapid core temperature fluctuations [16, 19, 
24, 28]. Esophageal monitoring is also considered a relia-
ble site for core temperature monitoring; however, its use 
is limited to patients who are orally intubated [1, 16, 21, 
22, 24, 26]. Additionally, administration of medications 
and fluids can transiently falsely alter the temperature in 
the esophagus [16].
There are several limitations to the study that warrant 
discussion. Our study size was relatively small (n = 20), 
Fig. 1 Comparison of paired temperature measurements. Plot comparing paired mean (x‑axis) with difference in mean (y‑axis). Hashed lines repre‑
sent population mean and 95% CI. All temperature measurements reported as °C
but it is comparable to other studies that compared tem-
perature monitoring systems [19, 24, 26, 28]. However, 
the amount of data (i.e., hourly temperature measure-
ments for up to 72 h) is far greater than what other stud-
ies utilized [17, 18, 23, 24, 26, 28]. Despite the patient 
size, there was good agreement between the continuous 
noninvasive temperature monitor, the bladder tempera-
ture probe, and esophageal temperature probe demon-
strated with the Bland–Altman analyses. We were unable 
to determine the accuracy of the continuous noninvasive 
temperature monitor in patients with spontaneous tem-
perature fluctuations although the patients in the study 
did have core temperature fluctuations, while on TTM, 
therefore one could confer that it is comparable. Finally, 
some might view 0.2–0.3  C deviation of the esophageal 
and bladder temperature probes as too high of a devia-
tion; however, all previous core temperature monitors, 
including bladder and esophageal temperature measure-
ment devices, have commonly utilized a higher threshold 
of 0.3–0.5 C [9, 11, 16, 21–24, 26, 28]. The major strength 
of the study was the continuous recording of both sets of 
temperatures into a clinical data acquisition storage sys-
tem, allowing for simultaneous real-time comparison.
Conclusions
Based on the data collected, the continuous noninvasive 
temperature monitor (3M™ Bair Hugger™ Temperature 
Monitoring System, St Paul, MN) device was in good 
agreement with both esophageal and bladder tempera-
tures and should be considered for use as the primary 
source of temperature monitoring in patients undergo-
ing TTM. Future studies should focus on developing 
connectivity with a continuous noninvasive temperature 
monitor as a suitable alternative to approximate core 
temperature during TTM.
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